Conference Coverage VIVA 2017 See All Content See past conferences Las Vegas, NV September 11, 2017 September 14, 2017 News Conference News Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients In a pharmacotherapy session, researchers discussed NOACs in the setting of endovascular disease and the potential role of reversal agents. News News Conference News ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA L.A. McKeown September 15, 2017 News Conference News EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017 News Conference News DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017 Slides Presentation Two-year Results from the IN.PACT Global Study Presenter: Thomas Zeller September 14, 2017 Presentation Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017 Presentation Results from the IN.PACT SFA Randomized Trial Presenter: Peter A. Schneider September 15, 2017 @TCTMD Follow Us
News Conference News Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients In a pharmacotherapy session, researchers discussed NOACs in the setting of endovascular disease and the potential role of reversal agents.
News Conference News ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA L.A. McKeown September 15, 2017
News Conference News EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017
News Conference News DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
Presentation Two-year Results from the IN.PACT Global Study Presenter: Thomas Zeller September 14, 2017
Presentation Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017
Presentation Results from the IN.PACT SFA Randomized Trial Presenter: Peter A. Schneider September 15, 2017